NCT06098742

Comparative Pharmacodynamics and Pharmacodynamics Equivalence of Antareit 800 mg/10 ml Oral Suspension and Riopan 800 mg Chewable Tablets in Healthy Volunteers

An Open-label, Randomized, Crossover Study to Investigate the Comparative Pharmacodynamics and Pharmacodynamics Equivalence of Antareit 800 mg/10 ml Oral Suspension and Riopan 800 mg Chewable Tablets in Healthy Volunteers.

• Status: Recruiting
• Phase: N/A
• Study type: Interventional
• Enrollment: 50 (estimated)
• Sponsor: Valenta Pharm JSC · Industry
• Sex: All
• Age: 18 Years – 45 Years
• Healthy volunteers: Accepted

Summary

Comparative study of the pharmacodynamic parameters and pharmacodynamic equivalence (bioequivalence) of drug Antareit 800 mg/10 ml oral suspension and drug Riopan 800 mg chewable tablets in healthy volunteers.

Conditions

• Heartburn
• Acid-dependent Diseases of the Gastrointestinal Tract
• Symptomatic Treatment of Gastric and Duodenal Ulcers

Interventions

Type	Name	Description
DRUG	Antareit	A single dose of T or R drug in each of 2 periods of the study 2 h prior to food intake

Timeline

• Start date: 2024-04-25
• Primary completion: 2024-10-20
• Completion: 2025-09-20
• First posted: 2023-10-24
• Last updated: 2024-07-22

Locations

2 sites across 1 country: Russia